Global Dog Vaccines Market Size By Type (Attenuated Live Vaccines, Conjugate Vaccines), By Application (< 6 Months, > 6 Months), By Geographic Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Dog Vaccines Market Size By Type (Attenuated Live Vaccines, Conjugate Vaccines), By Application (< 6 Months, > 6 Months), By Geographic Scope And Forecast
Dog Vaccines Market Size And Forecast
Dog Vaccines Market size was valued at USD 3.08 Billion in 2021 and is projected to reach USD 4.66 Billion by 2030, growing at a CAGR of 5.88% from 2022 to 2030.
The rise in the adoption of pet dogs is the major growth driver for the Dog Vaccines Market. Increasing awareness about vaccines to improve dog health and the rising occurrence of zoometric diseases in humans has triggered the demand for dog vaccines. Furthermore, growing investment in the R&D of vaccines by private companies and development in animal healthcare technology are the factors that are expected to support the growth of the market. The Global Dog Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Dog Vaccines Market Definition
Vaccination is a medical product that provides active immunity against a particular disease. Dog vaccine protects dogs from various infectious diseases which can cause illness and death if not treated. Dog vaccines help to improve animal health & lifespan of dogs and prevent the transmission of diseases from dog to dog or dog to human in a cost-effective manner. Dog vaccines are made from bacterial metabolites, viruses, and other organisms that protect dogs against harmful viruses such as canine distemper, canine hepatitis, canine par influenza, coronavirus, and many others. Vaccines are critical in maintaining a pet’s health.
However, not every pet requires vaccination against every disease. It is critical to discuss a vaccination protocol that is appropriate for pets with veterinarians. Age, medical history, surroundings, travel habits, and lifestyle are all things to consider. The majority of veterinarians strongly advise giving basic immunizations to healthy pets. Because of the universal danger of exposure, the severity of sickness, and the possibility of disease transmission to other dogs, as well as other animal species, also humans, core dog immunizations are deemed essential for all canines. The primary vaccines for diseases affecting dogs include canine parvovirus, canine distemper, hepatitis, and rabies.
Global Dog Vaccines Market Overview
Vaccines aid in the prevention of a variety of ailments that affect pets. Vaccinating the pet has long been thought to be one of the simplest ways to ensure that he lives a long and healthy life. There are many types and combinations of vaccines, as well as different vaccines for different diseases. Vaccination is a practice with risks and advantages that must be considered for each pet’s lifestyle and health. Your veterinarian can recommend a vaccination schedule that is both safe and effective for your particular animal. According to the American Animal Hospital Association’s Canine Task Force, the following dog vaccinations are considered to be core1. Canine Parvovirus, 2. Canine Distemper, 3. Hepatitis, 4. Rabies, 5. Leptospirosis.
In the US, rabies vaccinations are required by law in most states. The administration of the rabies vaccine is governed by the regulations of each state. The rabies vaccine is required in some locations once a year. Vaccinations are required every three years in some locations. Rabies vaccination documentation is required in practically all states. The American Animal Hospital Association (AAHA) published a set of vaccination guidelines in 2003, which were updated in 2006, to assist veterinarians in determining how often and which immunizations should be given to dogs. Many professionals in the field of canine health care, including veterinarians, immunologists, infectious disease specialists, and researchers, collaborated on these guidelines.
The US is a major market for dog vaccines. The country has the largest number of dogs as pets. According to the American Pet Products Association’s 2021-2022 National Pet Owners Survey, the country has over 69 million dogs as pets, which is expected to increase the demand for dog vaccines in the country. Dogs are also being increasingly adopted in the emerging Asia Pacific and Latin America regions. These regions are witnessing an increase in urbanization and nuclear families creating a demand for companion animals such as dogs. On the other hand, lack of awareness among underdeveloped regions and high prices of vaccination are the elements that might hinder market growth.
Global Dog Vaccines MarketSegmentation Analysis
The Global Dog Vaccines Market is Segmented on the basis of Type, Application, And Geography.
Dog Vaccines Market, By Type
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
Based on Type, The market is segmented into Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, and Subunit Vaccines. With the largest share of the Dog Vaccines Market, the Attenuated Live Vaccines segment dominated the type segment. By stimulating a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccines. Furthermore, it helps to lessen the need for booster vaccines that may be given orally and generates long-lasting and fast immunity, all of which contribute to the growth of the Dog Vaccines Market.
Dog Vaccines Market, By Application
- < 6 months
- > 6 Months
Based on Application, The market is segmented into < 6 Months and > 6 Months. > 6 months segment dominated the market. Dogs having aged more than 6 months are having more chances of a bite. Vaccinations of Dogs for more than 6 months are more effective due to Dog vaccines help to improve the animal health & lifespan of dogs and prevent the transmission of diseases from dog to dog or dog to human in a cost-effective manner. Dog vaccines are made from bacterial metabolites, viruses, and other organisms that protect dogs against harmful viruses such as canine distemper, canine hepatitis, canine par influenza, coronavirus, and many others.
Dog Vaccines Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of The World
On the basis of Geography, The Global Dog Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Because of the rise in pet ownership and the occurrence of many zoometric diseases, Asia-Pacific has a large market potential that Dog Vaccines Market trends. Due to the high demand for animal-based food products and companion animals, continuous research on novel vaccine production technologies has increased. Increased investment in animal healthcare industries has enhanced the development of novel vaccinations.
Key Players
The “Global Dog Vaccines Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Bayer AG, Vetoquinol S.A., Boehringer Ingelheim, Ceva, Eli Lilly and Company, Heska Corporation, Merck & Co., Inc., Virbac, Zoetis, and Elanco.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
- In January 2021, Merck & Co. announced the formation of a strategic partnership with the Street Dog Coalition in the U.S., to provide them with vaccines, medicines, and treatments for homeless pets.
- In April 2020, Boehringer Ingelheim U.K. collaborated with VetHelpDirect, which provided all the methods of a U.K. veterinarian. with free access to the online video consultation site for a period of three months during the epidemic.
- In August 2021, Zoetis announced its plan to acquire Jurox, an Australian independent animal health company. With the completion of this acquisition, Zoetis will be able to leverage the range of various Jurox products and expand its business globally. As Australia is the fifth largest Zoetis-funded market, this acquisition will help the company strengthen its market presence even further in the country.
- In October 2021, Boehringer Ingelheim announced an investment of 100 Mn euros to increase its animal vaccination capacity in France. This investment is designed to help the French government manage infectious diseases and other animal diseases that may affect public health in the country.
- In June 2020, Elanco obtained regulatory approval to acquire Bayer AG’s veterinary health business.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2018-2030 |
BASE YEAR | 2021 |
FORECAST PERIOD | 2022-2030 |
HISTORICAL PERIOD | 2018-2020 |
UNIT | Value (USD Billion) |
KEY COMPANIES PROFILED | Bayer AG, Vetoquinol S.A., Boehringer Ingelheim, Ceva, Eli Lilly and Company, Heska Corporation, Merck & Co., Inc., Virbac, Zoetis, and Elanco. |
SEGMENTS COVERED |
|
CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.